Edition:
India

Beijing Tiantan Biological Products Corp Ltd (600161.SS)

600161.SS on Shanghai Stock Exchange

23.37CNY
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
¥23.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,375,049
52-wk High
¥26.65
52-wk Low
¥14.00

Latest Key Developments (Source: Significant Developments)

Beijing Tiantan Biological Products Says 2018 Net Profit Down 56.6 Pct
Monday, 1 Apr 2019 

April 1 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS 2018 NET PROFIT DOWN 56.6 PERCENT Y/Y AT 509.5 MILLION YUAN ($75.95 million).  Full Article

Beijing Tiantan Biological Products Sees 2018 Net Profit Down 58 Percent Y/Y
Friday, 11 Jan 2019 

Jan 11 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS IT SEES 2018 NET PROFIT DOWN 58 PERCENT Y/Y FROM 1.2 BILLION YUAN ($178.05 million) YEAR EARLIER.  Full Article

Beijing Tiantan Biological Products' H1 Net Profit Down 72.7 Percent Y/Y
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS H1 NET PROFIT DOWN 72.7 PERCENT Y/Y AT 240.3 MILLION YUAN ($34.96 million).  Full Article

Beijing Tiantan Biological Products' Prelim H1 Net Profit Down 72.6 Percent Y/Y
Thursday, 19 Jul 2018 

July 19 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS PRELIM H1 NET PROFIT DOWN 72.6 PERCENT Y/Y AT 241.2 MILLION YUAN ($35.59 million).  Full Article

Beijing Tiantan Biological Products unit buys three blood products firms
Friday, 19 Jan 2018 

Jan 19(Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>:Says co acquires 10 percent stake in co's unit Chengdu Rongsheng Pharmaceuticals and holds 69.5 percent stake in the unit after acquisition .Says the unit buys three blood products firms.Previous news was disclosed on Dec. 1, 2017.  Full Article

Beijing Tiantan Biological Products' Controlling Shareholder To Increase Holdings
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS CONTROLLING SHAREHOLDER PLANS TO INCREASE SHAREHOLDINGS IN THE COMPANY FOR UP TO 100 MILLION YUAN ($15.15 million) WITHIN SIX MONTHS.  Full Article

Beijing Tiantan Biological Products unit obtains high-tech enterprise recognition and to enjoy tax preference
Friday, 8 Dec 2017 

Dec 8(Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>:Says its pharmaceutical subsidiary was recognized as high-tech enterprise, and to enjoy a tax preference of 15 percent for three years .  Full Article

Beijing Tiantan Biological Products' unit to buy stakes in 3 firms for 2.7 bln yuan
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>::SAYS IT PLANS TO BUY 10 PERCENT STAKE IN ITS BLOOD PRODUCTS UNIT FOR 622.8 MILLION YUAN ($94.26 million).SAYS UNIT PLANS TO BUY STAKES IN THREE BLOOD PRODUCTS FIRMS FOR A COMBINED 2.74 BILLION YUAN.  Full Article

Beijing Tiantan Biological Products sees 9-month net profit rise 483 pct y/y
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Beijing Tiantan Biological Products Corp Ltd <600161.SS>:Says it expects 9-month net profit to rise 483 percent y/y from 181.2 million yuan ($27.53 million) year ago.  Full Article